Trading at a discount across both intrinsic cash flow and relative peer multiples, indicating a strong margin of safety.
High-quality fundamentals with a strong composite quality score of 83/100, backed by robust profitability and solvency.
Analysts remain bullish, forecasting further upside expansion with consensus targets suggesting solid gains.
Verdict: High-quality compounder, with profitability as the only relative weakness.
Wall Street is highly bullish, projecting significant upside alongside robust expected earnings growth. However, capital return yields remain modest, anchored by a strong dividend yield, though free cash flow coverage appears tight.
BTG demonstrates strong business quality with robust profitability and healthy margins (highlighted by a massive 30.0% ROIC). This is paired with a moderately leveraged but stable balance sheet.
The company is driving exceptional top-line expansion (20.9% 3Y CAGR) paired with stable bottom-line earnings. This growth is supported by elite operational efficiency, sustaining an impressive 48.2% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | +60.9% | +20.9% | +11.3% | +18.6% | |
| EBITDA | $731.5M | — | +27.7% | — | — | |
| Net Income | $197.2M | +163.8% | +16.7% | — | — | |
| EPS (Diluted) | $0.14 | +158.3% | +5.3% | -13.8% | — | |
| Free Cash Flow | $359.7M | +380.6% | -39.5% | -37.0% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 51.6% | 42.5% | 41.2% | 38.3% |
| Operating Margin | 48.2% | 37.3% | 36.3% | 34.0% |
| Net Margin | 14.7% | -6.5% | 3.8% | 9.6% |
| FCF Margin | 11.5% | 11.3% | 15.6% | 12.3% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.11 | $0.19 | +72.7% | ||
| Q1'26 | $0.20 | $0.11 | -45.0% | ||
| Q4'25 | $0.15 | $0.14 | -6.7% | ||
| Q3'25 | $0.15 | $0.12 | -20.0% | ||
| Q2'25 | $0.08 | $0.09 | +12.5% | ||
| Q1'25 | $0.07 | $0.01 | -85.7% | ||
| Q4'24 | $0.05 | $0.02 | -60.0% | ||
| Q3'24 | $0.08 | $0.06 | -25.0% |
Total return is +18.4% (1Y), lagging the benchmark by -6.6%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | -3.6% | -12.9% | — |
| 1Y | +18.4% | -6.6% | +2.2% |
| 3YCAGR | +9.8% | -8.9% | +10.2% |
| 5YCAGR | +2.8% | -9.9% | +16.5% |
| 10YCAGR | +8.6% | -4.5% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about B2Gold Corp. (BTG) valuation, health, and returns.
B2Gold Corp. is estimated to be undervalued under our discounted cash flow framework. relative multiples indicate the stock is Cheap versus peers compared to industry peers. undervalued (implying +229.1% upside to DCF intrinsic value of $14.15)
B2Gold Corp. has multiple valuation anchors: DCF Intrinsic Value: $14.15 | Peer Relative Fair Value: $6.64 | Wall Street Analyst Target: $6.50 (implying +51.2% upside). A convergence of these signals offers higher conviction.
B2Gold Corp. displays excellent financial health with a composite quality score of 83/100, supported by a Altman Z-Score of 2.7 (grey zone), Piotroski F-Score of 6/9, Return on Invested Capital (ROIC) of 30.0%.
B2Gold Corp. pays a 1.7% dividend yield, covered by a 26% payout ratio with 0 years of growth, supplemented by a 0.2% buyback yield.
B2Gold Corp.'s current growth trajectory is Accelerating. The company achieved +60.9% 1Y revenue growth and +158.3% 1Y EPS growth, compared to its 3Y revenue CAGR of +20.9%.
Wall Street consensus is Buy based on 9 analysts, beating EPS expectations in 25% of recent quarters with a 1-quarter streak. The consensus price target represents a +51.2% change from current levels.
Investment risks for B2Gold Corp. include: -37.7% 1-year max drawdown, high beta (1.70x market volatility). Volatility risk is characterized by a beta of 1.70x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.